Phase I drug Flashcards
CYPs in humans which are important in metabolising drugs
- 3A4 –> liver
- 2D6 –> not well expressed
Important properties of CYPs that can influence therapy
- inhibited drug: drugs compete with each other for enzymes is high and gives rise to pharmacokinetics drug-drug interaction
- some are inducible- where exposure of the drug can increase the expression or amount of CYP in the liver
Pharmacogenetic variation
some individuals who carry defect copies of CYD2D6 unable to metabolise the drug which rely on enzyme to eliminate , thus there is build up of the drug - inhibitory drug interaction
CYP3A4
- major in human liver
- many drugs metabolised by this enzyme
- readily inhibited (inhibitory drug interaction) i.e. grapejuice
- Highly inducible e.g. St John’s wort or rifampicin
CYP3A4 : Some important drugs classes include
Statins (high cholesterol)
HIV protease inhibitors – drug used to elongate the drugs for HIV by inhibiting the degradation of the drugs used for HIV
Benzodiazepines (high blood pressure)
Calcium channel blockers
CYP3A4 inhibition: between triazolam and diltiazem
triazolam is a CYP3A4 substrate.
When T and D are together, D prolongs the half-life and increased Cmax. Thus the levels of Triazolam have increase as not being eliminated. When diltiazem levels decrease, the blood levels will come down and allow Triazolem to decrease as well
Grapejuice vs Felodipine
It was found that grapejuice increased absorbed drug and bioavalibility. increased felodipine Cmax
Grapejuice inhibits CYP3A4 intestinal. Thus undergoes presystemic oxidation in the intestines.
GJ increases the amount of felodipine absorbed
CYP3A4 induction
- clinical significance
- increased clearance of the drug metabolised by CYP3A4
- diminishes therapeutic effect
- reduces systemic exposure
- this reduces the amount of drug absorbed into the body as shortening half-life of drug
Example of CYP3A4 induction
Pregnane X-receptor:
- forms a dimer with RXR
- dimer translocate to the nucleus where it is able to activate the expression of genes and switch on enzymes like CYP3A4
CYP1A2
- metabolism
- gene is inducible by cigrette smoke
- aryl hydrocarbon receptor (AhR)
- PAH moves into the cell to interact with AhR in the nucleus, which stimulates the expression
CYP1A2
- clinical significance
- smokers who receive toxic drugs (antipsychotic drug) i.e. clozapine rapidly eliminate that drug
- can be toxic if the smoker stops smoking, and continues with that dosage, the CYP1A2 will decrease, thus less of the drug is being cleared and more building up
CYP2D6
- debrisoquine hydroxylase
- antihypertensive drug
- varied dosage for each individual as the rate of drug being metabolised varies for each patient
CYP2D6
- codeine and tamoxifen
Pro-drugs, low activity but once when in body with the activation of CYP2D6. People who lack this enzyme, are not able to get the pain relief or treatment for breast cancer
CYP2D6 - extensive metabolisers
carry two active alleles - normal people
poor metabolisers
carry two non-functional alleles - exhibit slow clearance of CYP2D6 subtrates and poor activation of pro-drugs i.e. codeine